
To guarantee the highest purity and therapeutic efficacy, we adhere to strict global standards
Esomeprazole is a critical Active Pharmaceutical Ingredient (API) belonging to the Proton Pump Inhibitors (PPIs) class. As the active (S)-isomer of omeprazole, it offers enhanced efficacy and superior bioavailability in inhibiting gastric acid production. We supply Esomeprazole, typically in its Magnesium Trihydrate or Sodium salt form, ensuring stability and compliance with the highest quality standards for enteric formulations.
Standard oral formulations.
We supply the API in the form of ready-to-fill enteric-coated pellets, reducing complex manufacturing steps for pharmaceutical companies.
Sodium salt for Intravenous (IV) injection for acute bleeding or dysphagia.
High water solubility of the Sodium salt, suitable for sterile injectable preparations.
Oral suspensions for pediatric or dysphagia patients.
Optimal stability in pH-adjusted suspension systems.
The product conforms to the specified requirements of the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and/or British Pharmacopoeia (BP).
A detailed CoA is issued with every batch, outlining potency, purity profile, and microbiological testing verification.
A comprehensive Drug Master File is available to support registration submissions to regulatory authorities worldwide.
Production takes place in certified facilities that strictly adhere to current Good Manufacturing Practices (cGMP).